2009-2017年美国儿童发育障碍患病率及趋势
该研究基于2009-2017年美国国家健康访谈调查,分析3-17岁儿童10种发育障碍的全国患病率及变化趋势。结果显示,任何发育障碍患病率从16.2%升至17.8%(P<.001),注意缺陷多动障碍、孤独症谱系障碍和智力障碍患病率显著增加,而其他发育迟缓显著下降。
要点
- 2009-2017年美国3-17岁儿童任何发育障碍患病率从16.2%升至17.8%。
- 注意缺陷多动障碍患病率从8.5%升至9.5%,孤独症谱系障碍从1.1%升至2.5%。
- 智力障碍患病率从0.9%升至1.2%,其他发育迟缓从4.7%降至4.1%。
核心结论
- 2009至2017年间,美国3-17岁儿童发育障碍总体患病率显著上升。
- 不同人口学和社会经济亚组的患病率变化可能反映意识提高和医疗可及性改善。
研究设计与样本
- 研究使用2009至2017年美国国家健康访谈调查数据,该调查为全国代表性调查,覆盖非机构化平民人口。
- 由家长报告医生或其他医疗专业人员对10种发育障碍的诊断。
主要发现
- 任何发育障碍患病率从2009-2011年的16.2%升至2015-2017年的17.8%(P<.001)。
- 注意缺陷多动障碍患病率从8.5%升至9.5%(P<.01)。
- 孤独症谱系障碍患病率从1.1%升至2.5%(P<.001)。
- 智力障碍患病率从0.9%升至1.2%(P<.05)。
- 其他发育迟缓患病率从4.7%降至4.1%(P<.05)。
关键数值与推荐
- 任何发育障碍总体患病率:16.2%升至17.8%(P<.001)。
- 注意缺陷多动障碍患病率:8.5%升至9.5%(P<.01)。
- 孤独症谱系障碍患病率:1.1%升至2.5%(P<.001)。
- 智力障碍患病率:0.9%升至1.2%(P<.05)。
- 其他发育迟缓患病率:4.7%降至4.1%(P<.05)。
临床怎么用
- 儿科医生应关注发育障碍患病率上升的趋势,在临床中提高对注意缺陷多动障碍、孤独症谱系障碍和智力障碍的识别。
- 对于男孩、较大儿童、非西班牙裔白人和西班牙裔儿童、仅私立保险儿童、出生体重≥2500g儿童、城市地区儿童及母亲教育程度较低儿童,需注意发育障碍患病率增加。
局限性
- 发育障碍诊断基于家长报告,可能存在回忆偏倚或报告偏倚。
- 研究为横断面调查,无法确定患病率变化的原因。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To study the national prevalence of 10 developmental disabilities in US children aged 3 to 17 years and explore changes over time by associated demographic and socioeconomic characteristics, using the National Health Interview Survey. METHODS: Data come from the 2009 to 2017 National Health Interview Survey, a nationally representative survey of the civilian noninstitutionalized population. Parents reported physician or other health care professional diagnoses of attention-deficit/hyperactivity disorder; autism spectrum disorder; blindness; cerebral palsy; moderate to profound hearing loss; learning disability; intellectual disability; seizures; stuttering or stammering; and other developmental delays. Weighted percentages for each of the selected developmental disabilities and any developmental disability were calculated and stratified by demographic and socioeconomic characteristics. RESULTS: From 2009 to 2011 and 2015 to 2017, there were overall significant increases in the prevalence of any developmental disability (16.2%-17.8%, P < .001), attention-deficit/hyperactivity disorder (8.5%-9.5%, P < .01), autism spectrum disorder (1.1%-2.5%, P < .001), and intellectual disability (0.9%-1.2%, P < .05), but a significant decrease for any other developmental delay (4.7%-4.1%, P < .05). The prevalence of any developmental disability increased among boys, older children, non-Hispanic white and Hispanic children, children with private insurance only, children with birth weight ≥2500 g, and children living in urban areas and with less-educated mothers. CONCLUSIONS: The prevalence of developmental disability among US children aged 3 to 17 years increased between 2009 and 2017. Changes by demographic and socioeconomic subgroups may be related to improvements in awareness and access to health care.
引用
- Zablotsky B, Black LI, Maenner MJ, et al. Prevalence and Trends of Developmental Disabilities among Children in the United States: 2009-2017. Pediatrics. 2019. PMID: 31558576. doi:10.1542/peds.2019-0811
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。